InvestorsHub Logo
Followers 69
Posts 6645
Boards Moderated 0
Alias Born 02/10/2010

Re: art2426 post# 150934

Wednesday, 09/12/2018 11:08:08 AM

Wednesday, September 12, 2018 11:08:08 AM

Post# of 333453
Understand your concerns about deals getting drug out Art

However I don't think that you can use Mundiphama as an example. This deal was first mentioned by KN on the 1/22/2018 interview. KN's words were "I had a call yesterday with Mundipharma, Mundipharma is going to pick up the product in Australia and 8 other countries."

7/23/2018 we had a PR stating Mundipharma had acquired the distribution rights for Australia and New Zealand. Considering that Mundi had to purchase the rights from another distributor this seems like a reasonable time frame.

https://globenewswire.com/news-release/2018/07/23/1540578/0/en/BioElectronics-ActiPatch-Musculoskeletal-Therapy-Added-to-Mundipharma-Australia-s-Pain-Portfolio.html

9/11/2018 AW confirmed that 5 more countries were being added in his interview. That brings the total to 7 countries for which Mundi is now the ActiPatch distributor.


Australia
New Zealand
Malaysia
Thailand
Indonesia
Singapore
Philippines